Bryant Fong serves as Executive at Neos Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Bryant Fong has executed 9 insider transactions totaling $5.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 26, 2024 involved receiving (via award) 24,040 shares valued at $0.
Bryant Fong currently holds 83,941 shares of Neos Therapeutics, Inc. (NEOS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bryant Fong has been a net seller of NEOS stock. They have purchased $9.8K and sold $5.5M worth of shares.
Bryant Fong's most recent insider trade was on Feb 26, 2024, when they sold 24,040 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $3.87 |
| Discretionary |
| Mar 6, 2023 | ADMA | $0 | Award | 25,815 | $N/A | Discretionary |
| Mar 7, 2022 | ADMA | $0 | Award | 26,586 | $N/A | Discretionary |
| Mar 19, 2021 | NEOS | $0 | Disposition | 24,953 | $N/A | Discretionary |
| Jun 10, 2020 | NEOS | $0 | Award | 23,453 | $N/A | Discretionary |
| Feb 28, 2020 | ADMA | $0 | Award | 7,500 | $N/A | Discretionary |
| Feb 28, 2020 | ADMA | $0 | Award | 7,500 | $N/A | Discretionary |
| Aug 31, 2016 | NEOS | $9.8K | Purchase | 1,500 | $6.54 | Discretionary |